Penn Medicine Provider
Breast Surgery
Jami D. Rothman, MD, ScM
4.9
(321)
Accepting new patients
Sees patients age 15 and up
Penn Breast Surgery Perelman
Make an appointmentCall 215-615-2992

About me

  • Assistant Professor of Clinical Surgery

Dr. Rothman received her undergraduate degree from Cornell University, and her Master of Science in Public Health from Harvard University. While at Harvard, she studied the impact of racism and poverty on cancer prevention in low-income populations, as well as the intertwining of provider- and systems-level interventions to measure their effects on cancer screening and early detection.

She received her medical degree from the Jacobs School of Medicine and Biomedical Sciences at the University at Buffalo, where she stayed to complete her general surgery residency. She subsequently completed her fellowship in breast surgical oncology at the University of California, San Francisco, where she was trained in some of the most innovative operative techniques, including nipple-sparing mastectomies, tumor and sentinel node localization, intraoperative radiation therapy, and oncoplastic surgery.

Dr. Rothman’s research has focused on the active surveillance of ductal carcinoma in situ (DCIS), intraoperative radiation therapy, as well as the application of precision medicine to the prevention and treatment of breast cancer. She is additionally interested in the racial and ethnic disparities in breast cancer surgery delay and the subsequent effects on stage migration and upstaging of disease.

Education and training

  • Medical School: State University of New York at Buffalo
  • Residency: University at Buffalo, Jacobs School of Medicine and Biomedical Sciences
  • Fellowship: UCSF Medical Center at Mount Zion

What my patients think about me

Average Rating
4.9

321 reviews

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

June 2025
5.0
5.0
the visit went well
June 2025
5.0
5.0
excellent clinician
May 2025
5.0
5.0
dr. rothman is great. she listens and gets to know you. she listens to any concerns and explains things very well.
May 2025
5.0
5.0
really appreciated the way dr rothman explained my type of cancer to where it made sense and helping me understand all of my options. she has a calm and sincere way about her.

Insurance accepted

My Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Pennsylvania Hospital: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
Dr. Rothman is a Penn Medicine physician.

Qualifications and experience

Treatments and Conditions

My research

Sorice-Virk S, Patel V, Christopher AN, Morris MP, Broach RB, Rothman JD, Serletti JM Patient perceptions of cancer and reconstructive care during the COVID-19 pandemic , Plastic Surgery, 32(2): 2024,283-291

Berkowitz CL, Perez-Rojas S, Reddy KP, Hulse S, Jarrell K, Collins J, Elmore LC, Fishman RH, Mateo AM, Newman A, Rothman JD, Sataloff DM, Tchou JC, Zhang JQ, McCarthy AM, Fayanju OM Sociodemographic disparities within pediatric breast cancer , Presented at the American Society of Breast Surgeons (ASBrS) Annual Meeting, Orlando, FL: 2024

Reddy K, Berkowitz C, Jarrell K, Berger R, Hulse S, Elmore LC, Fishman R, Mateo A, Rothman JD, Sataloff D, Tchou J, Zhang JQ, McCarthy AM, Fayanju OM Association between rurality and time to surgery among breast cancer patients is mediated by geographic proximity to care , Annals of Surgical Oncology, 24(Suppl 1): 2024,S238

Jarrell K, Perez-Rojas S, Reddy K, Berkowitz C, Berger R, Hulse S, Brooks A, Elmore LC, Fishman R, Mateo A, Murray A, Newman A, Pierotti M, Rothman JD, Sataloff D, Tchou J, Zhang JQ, Shah P, McCarthy AM, Fayanju OM Disparities, time to surgery, and survival in contralateral prophylactic mastectomy: A review of the National Cancer Database , Annals of Surgical Oncology, 24(Suppl 1): 2024,S111-S112

Reddy K, Berkowitz C, Jarrell K, Berger R, Hulse S, Elmore LC, Mateo A, Rothman JD, Sataloff D, Tchou J, Zhang JQ, McCarthy AM, Fayanju OM Differences in time to surgery predict rural-urban differences in survival among women with invasive, non-metastatic breast cancer , Annals of Surgical Oncology, 24(Suppl 1): 2024,S106

Reddy KP, Jarrell K, Berkowitz C, Hulse S, Brooks AD, Elmore LC, Fishman R, Greenup RA, Mateo AM, Murray AB, Newman AM, Rothman JD, Sataloff DM, Tchou JC, Zhang JQ, Fayanju OM Delayed/forgone care is associated with increased resource utilization among women with breast cancer , Presented at the Academic Surgical Congress, Washington, DC: 2024

Reddy KP, Jarrell K, Berkowitz C, Hulse S, Brooks AD, Elmore LC, Fishman R, Greenup RA, Mateo AM, Murray AB, Newman AM, Rothman JD, Sataloff DM, Tchou JC, Zhang JQ, Fayanju OM Women with breast cancer who delay/forego care face increased inpatient expenditures , Presented at Academic Surgical Congress, Washington, DC: 2024

Goldbach, MM; Burkbauer, L; Bharani, T; Williams, AD; Keele, L; Rothman, J; Jankowitz, R; Tchou, JC. Effectiveness of a short duration of neoadjuvant endocrine therapy in patients with HR+ breast cancer - An NCDB analysis (2004-2016) , Annals of Surgical Oncology, 28(13): 2021,8651-8662

Goldbach M, Burkbauer L, Keele L, Nazarian S, Rothman J, Tchou J Clinical characteristics of long-term survivors of metastatic HER2+ breast cancer , Annals of Surgical Oncology, 27(Suppl 2): 2020,S466

Malinovitch A, Goldbach M, Pomponio M, Burkbauer L, Keele L, Nazarian S, Rothman J, Tchou J The value of OncotypeDX (ODX) testing in patients with T1AN0 hormone receptor (HR) (+) breast cancer , Annals of Surgical Oncology, 27(Suppl 2): 2020,S472-S473